Is Caplyta (lumateperone) an SSRI?
No. Caplyta (lumateperone) is not an SSRI. SSRI antidepressants (like fluoxetine, sertraline, or escitalopram) primarily target serotonin reuptake by blocking the serotonin transporter.
What class is Caplyta instead?
Caplyta (lumateperone) is an antipsychotic medicine used for certain psychiatric conditions, including bipolar depression and schizophrenia. It works through multiple brain receptor pathways rather than functioning as a serotonin reuptake inhibitor like SSRIs.
Why do people confuse it with SSRIs?
Some patients look at treatment for depression symptoms and assume all depression medicines are SSRIs. Caplyta is used in bipolar depression, but its mechanism and drug class are different from SSRI antidepressants.
What should you check if you’re comparing medications?
If you want to know whether a medicine is an SSRI, look at whether it’s labeled as an SSRI or has an SSRI generic name (for example, fluoxetine, sertraline, paroxetine, citalopram, escitalopram). Caplyta’s generic name is lumateperone, which is not in the SSRI group.